Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 3
2005 5
2006 3
2007 4
2008 2
2009 1
2010 3
2011 5
2012 1
2013 3
2014 4
2015 8
2016 6
2018 3
2019 5
2020 3
2021 3
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Female reproduction and the microbiota in mammals: Where are we?
Garcia-Garcia RM, Arias-Álvarez M, Jordán-Rodríguez D, Rebollar PG, Lorenzo PL, Herranz C, Rodríguez JM. Garcia-Garcia RM, et al. Among authors: herranz c. Theriogenology. 2022 Dec;194:144-153. doi: 10.1016/j.theriogenology.2022.10.007. Epub 2022 Oct 8. Theriogenology. 2022. PMID: 36252450 Free article. Review.
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Mateo F, He Z, Mei L, de Garibay GR, Herranz C, García N, Lorentzian A, Baiges A, Blommaert E, Gómez A, Mirallas O, Garrido-Utrilla A, Palomero L, Espín R, Extremera AI, Soler-Monsó MT, Petit A, Li R, Brunet J, Chen K, Tan S, Eaves CJ, McCloskey C, Hakem R, Khokha R, Lange PF, Lázaro C, Maxwell CA, Pujana MA. Mateo F, et al. Among authors: herranz c. Nat Commun. 2022 Apr 7;13(1):1895. doi: 10.1038/s41467-022-29335-z. Nat Commun. 2022. PMID: 35393420 Free PMC article.
Immune Cell Associations with Cancer Risk.
Palomero L, Galván-Femenía I, de Cid R, Espín R, Barnes DR, Cimba, Blommaert E, Gil-Gil M, Falo C, Stradella A, Ouchi D, Roso-Llorach A, Violan C, Peña-Chilet M, Dopazo J, Extremera AI, García-Valero M, Herranz C, Mateo F, Mereu E, Beesley J, Chenevix-Trench G, Roux C, Mak T, Brunet J, Hakem R, Gorrini C, Antoniou AC, Lázaro C, Pujana MA. Palomero L, et al. Among authors: herranz c. iScience. 2020 Jul 24;23(7):101296. doi: 10.1016/j.isci.2020.101296. Epub 2020 Jun 20. iScience. 2020. PMID: 32622267 Free PMC article.
Risk of breast cancer in patients with lymphangioleiomyomatosis.
Nuñez O, Baldi BG, Radzikowska E, Carvalho CRR, Herranz C, Sobiecka M, Torre O, Harari S, Vergeer MAMH, Kolbe J, Pollán M, Pujana MA. Nuñez O, et al. Among authors: herranz c. Cancer Epidemiol. 2019 Aug;61:154-156. doi: 10.1016/j.canep.2019.06.004. Epub 2019 Jun 28. Cancer Epidemiol. 2019. PMID: 31260937
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Espín R, Baiges A, Blommaert E, Herranz C, Roman A, Saez B, Ancochea J, Valenzuela C, Ussetti P, Laporta R, Rodríguez-Portal JA, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Villar-Piqué A, Diaz-Lucena D, Llorens F, Casanova Á, Molina-Molina M, Plass M, Mateo F, Moss J, Pujana MA. Espín R, et al. Among authors: herranz c. Mol Cancer Res. 2021 Nov;19(11):1840-1853. doi: 10.1158/1541-7786.MCR-21-0220. Epub 2021 Jul 26. Mol Cancer Res. 2021. PMID: 34312290 Free PMC article.
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function.
Farré X, Espín R, Baiges A, Blommaert E, Kim W, Giannikou K, Herranz C, Román A, Sáez B, Casanova Á, Ancochea J, Valenzuela C, Ussetti P, Laporta R, Rodríguez-Portal JA, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Tena-Garitaonaindia M, Sánchez de Medina F, Mateo F, Molina-Molina M, Won S, Kwiatkowski DJ, de Cid R, Pujana MA. Farré X, et al. Among authors: herranz c. ERJ Open Res. 2022 Jan 24;8(1):00375-2021. doi: 10.1183/23120541.00375-2021. eCollection 2022 Jan. ERJ Open Res. 2022. PMID: 35083324 Free PMC article.
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C, Mateo F, Baiges A, Ruiz de Garibay G, Junza A, Johnson SR, Miller S, García N, Capellades J, Gómez A, Vidal A, Palomero L, Espín R, Extremera AI, Blommaert E, Revilla-López E, Saez B, Gómez-Ollés S, Ancochea J, Valenzuela C, Alonso T, Ussetti P, Laporta R, Xaubet A, Rodríguez-Portal JA, Montes-Worboys A, Machahua C, Bordas J, Menendez JA, Cruzado JM, Guiteras R, Bontoux C, La Motta C, Noguera-Castells A, Mancino M, Lastra E, Rigo-Bonnin R, Perales JC, Viñals F, Lahiguera A, Zhang X, Cuadras D, van Moorsel CHM, van der Vis JJ, Quanjel MJR, Filippakis H, Hakem R, Gorrini C, Ferrer M, Ugun-Klusek A, Billett E, Radzikowska E, Casanova Á, Molina-Molina M, Roman A, Yanes O, Pujana MA. Herranz C, et al. EMBO Mol Med. 2021 Sep 7;13(9):e13929. doi: 10.15252/emmm.202113929. Epub 2021 Aug 11. EMBO Mol Med. 2021. PMID: 34378323 Free PMC article.
Study of breast cancer incidence in patients of lymphangioleiomyomatosis.
Nuñez O, Román A, Johnson SR, Inoue Y, Hirose M, Casanova Á, de Garibay GR, Herranz C, Bueno-Moreno G, Boni J, Mateo F, Petit A, Climent F, Soler T, Vidal A, Sánchez-Mut JV, Esteller M, López JI, García N, Gumà A, Ortega R, Plà MJ, Campos M, Ansótegui E, Molina-Molina M, Valenzuela C, Ussetti P, Laporta R, Ancochea J, Xaubet A, Pollán M, Pujana MA. Nuñez O, et al. Among authors: herranz c. Breast Cancer Res Treat. 2016 Feb;156(1):195-201. doi: 10.1007/s10549-016-3737-8. Epub 2016 Mar 7. Breast Cancer Res Treat. 2016. PMID: 26951504 Free PMC article.
64 results